Related references
Note: Only part of the references are listed.In vitro 3D models of tumor-immune system interaction
Christian Hirt et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
Alexandra Naba et al.
BMC CANCER (2014)
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
M. M. Gerlach et al.
BRITISH JOURNAL OF CANCER (2014)
Endothelial Cell-Secreted EGF Induces Epithelial to Mesenchymal Transition and Endows Head and Neck Cancer Cells with Stem-like Phenotype
Zhaocheng Zhang et al.
CANCER RESEARCH (2014)
Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalized therapeutic assays
Neil Ashley et al.
JOURNAL OF PATHOLOGY (2014)
Cellular Localization, Invasion, and Turnover Are Differently Influenced by Healthy and Tumor-Derived Extracellular Matrix
Luca Genovese et al.
TISSUE ENGINEERING PART A (2014)
Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers
Padhma Radhakrishnan et al.
CANCER RESEARCH (2013)
Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type K-RAS Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial
Lillian L. Siu et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A comparative analysis of computational approaches to relative protein quantification using peptide peak intensities in label-free LC-MS proteomics experiments
Melissa M. Matzke et al.
PROTEOMICS (2013)
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Antonija Kreso et al.
SCIENCE (2013)
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
Daniel Hofmann et al.
TRIALS (2013)
In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels
Hidekazu Sekine et al.
NATURE COMMUNICATIONS (2013)
Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death Switch
Vineshkumar Thidil Puliyappadamba et al.
CELL REPORTS (2013)
Human blood-derived fibrin releasates: Composition and use for the culture of cell lines and human primary cells
Thierry Burnouf et al.
BIOLOGICALS (2012)
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
Osvaldo Pontiggia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone et al.
CANCER CELL (2012)
Paracrine Receptor Activation by Microenvironment Triggers Bypass Survival Signals and ALK Inhibitor Resistance in EML4-ALK Lung Cancer Cells
Tadaaki Yamada et al.
CLINICAL CANCER RESEARCH (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis
George S. Karagiannis et al.
ONCOTARGET (2012)
Phosphoproteomic Analysis of Signaling Pathways in Head and Neck Squamous Cell Carcinoma Patient Samples
Mitchell J. Frederick et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Chemoresponse assay for evaluating response to sunitinib in primary cultures of breast cancer
Sarah L. Suchy et al.
CANCER BIOLOGY & THERAPY (2011)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Christina Scheel et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis
Elisa Benedettini et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts
Mukund Seshadri et al.
CANCER BIOLOGY & THERAPY (2010)
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
Qing Sheng et al.
CANCER CELL (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Evidence for the Therapeutic Potential of Ex Vivo Expanded Human Endothelial Progenitor Cells Using Autologous Serum
Takanori Shumiya et al.
CIRCULATION JOURNAL (2010)
Lung Cancer Serum Biomarker Discovery Using Glycoprotein Capture and Liquid Chromatography Mass Spectrometry
Xuemei Zeng et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
Douglas W. McMillin et al.
NATURE MEDICINE (2010)
Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia
Todd W. Ridky et al.
NATURE MEDICINE (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Valentina Vaira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
Modelling tissues in 3D: the next future of pharmaco-toxicology and food research?
Giovanna Mazzoleni et al.
GENES AND NUTRITION (2009)
Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer
Salvatore Siena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Extraction and Assembly of Tissue-Derived Gels for Cell Culture and Tissue Engineering
Shiri Uriel et al.
TISSUE ENGINEERING PART C-METHODS (2009)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Enabling personalized cancer medicine through analysis of gene-expression patterns
Laura J. van 't Veer et al.
NATURE (2008)
Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers
Lambert C. M. Ngoka
PROTEOME SCIENCE (2008)
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Sreenath V. Sharma et al.
GENES & DEVELOPMENT (2007)
Modeling tissue morphogenesis and cancer in 3D
Kenneth M. Yamada et al.
CELL (2007)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Support vector ordinal regression
Wei Chu et al.
NEURAL COMPUTATION (2007)
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
JA Foekens et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
JC Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Paradigm shift in the treatment of head and neck cancer: The role of neoadjuvant chemotherapy
MR Posner
ONCOLOGIST (2005)
Chemotherapy sensitivity and resistance assays: A systematic review
DJ Samson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients
J Akervall et al.
CLINICAL CANCER RESEARCH (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts
F Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium
VM Weaver et al.
CANCER CELL (2002)
Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34+ progenitor cells
MRI Young et al.
HUMAN IMMUNOLOGY (2001)
Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract
KB Collins et al.
NATURE MEDICINE (2000)
Share Paper
